Device companies drawn into Danish drug advertising concerns:
This article was originally published in Clinica
Executive Summary
The Danish medical device industry association, Medicoindustrien, is concerned that the Danish Board of Drug Advertising is using aggressive methods to make medical device companies join an arrangement between the pharmaceutical industry and the Medical Association, in order to subject them to its decisions. The Board has ruled that companies that sell products approved as medicinal products, alongside medical devices must join, although it has reassured Medicoindustrien that it will only enforce its rules in relation to the sale of medicinal products. Medicoindustrien is now speculating that it might be compelled to appoint a similar board, unless its members stick closely to the industry association's own ethical guidelines.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.